secwatch.observer — SEC 8-K summary
======================================

Issuer:     EKSO BIONICS HOLDINGS, INC. (CHRN)
CIK:        0001549084
Form:       8-K
Filed at:   2026-10-06T21:20:39+00:00
Accession:  0001493152-26-046010
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02
LLM model:  deepseek-v4.1-flash:cloud@v2

ChronoScale director Scott Davis resigns after Ekso sale; gets $709,500 and 51,626 RSUs
--------------------------------------------------------------------------------

- Scott Davis, Ekso Bionics CEO and ChronoScale board member, resigned from the board effective October 3, 2026, with no disagreements cited; the Ekso sale closed September 30, 2026.
- Davis received 51,626 fully vested restricted stock units granted October 2, 2026, plus a $709,500 lump-sum cash payment payable within 30 days under a Release Agreement.
- The Release Agreement includes a general release of claims and stands in lieu of any payment under the Nov. 5, 2025 Change in Control and Severance Agreement; the Phantom RSU Agreement is unchanged.
- ChronoScale common stock trades on the Nasdaq Capital Market under CHRN; CFO Jerome Wong signed the report dated October 6, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1549084/000149315226046010/0001493152-26-046010-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1549084/000149315226046010/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-046010

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer